FMR LLC 13D and 13G filings for Prelude Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-10 08:53 am Sale |
2024-01-09 | 13G | Prelude Therapeutics Incorporated PRLD |
FMR LLC | 264,686 0.630% |
-4,613,865 (-94.57%) |
Filing |
| 2023-02-10 09:08 am Purchase |
2023-02-09 | 13G | Prelude Therapeutics Incorporated PRLD |
FMR LLC | 4,878,551 10.193% |
288,960 (+6.30%) |
Filing |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Prelude Therapeutics Incorporated PRLD |
FMR LLC | 4,589,591 9.589% |
-1,349,341 (-22.72%) |
Filing |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Prelude Therapeutics Incorporated PRLD |
FMR LLC | 5,938,932 12.578% |
-413,049 (-6.50%) |
Filing |
| 2021-02-10 09:23 am Purchase |
2021-02-09 | 13G | Prelude Therapeutics Incorporated PRLD |
FMR LLC | 6,351,981 13.747% |
2,142,018 (+50.88%) |
Filing |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Prelude Therapeutics Incorporated PRLD |
FMR LLC | 4,209,963 9.633% |
4,209,963 (New Position) |
Filing |